DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Terlipressin
Terlipressin
Vasopressin in Pediatric Critical Care
Glypressin Ferring Pharmaceuticals Pty Ltd PM-2010-03182-3-3 Final 26 November 2012
Largescale Synthesis of Peptides
Vasopressin and Terlipressin in Adult Vasodilatory Shock: a Systematic Review and Meta-Analysis of Nine Randomized Controlled Tr
Hemmo Pharmaceuticals Private Limited
NDA 22-231 Terlipressin for the Treatment of HRS Type 1
Auspar Attachment 1: Product Information for Lucassin (Terlipressin)
< MOH Approved Drugs List >
Effects of Terlipressin As Early Treatment for Protection of Brain in A
Queensland Health List of Approved Medicines
Renal and Circulatory Dysfunction in Cirrhosis: Current Management and Future Perspectives
Describe the Mechanism of Action ,Types,Doses,Side Effects, Indications and Contraindications of of the Drugs Affecting Renal System- II (ANTI-DIURETICS)
Essential Medicines List Libyan
Guidelines for the Assessment and Management of Hyponatraemia
Terlipressin-Related Acute Myocardial Infarction: a Case Report and Literature Review
Vasopressin: Mechanisms of Action on the Vasculature in Health and in Septic Shock
Mallinckrodt Pharmaceuticals NDA #022231 Terlipressin Advisory Committee Briefing Document
THINWES CARTON.Cdr
Top View
Antidiuretic Activity of Terlipressin (Triglycyl-Lysine Vasopressin) - Role of Pressure Natriuresis
Synthetic Peptides by Dr Olga Kolaj-Robin
Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: a Protocol for a Systematic Review
Our Cgmp Peptide for Your Innovation, Where Chemistry Meets
Managing Hyponatremia in Cirrhosis
6. Drugs Used in the Treatment of Disorders of the Endocrine System
M/S. Hemmo Pharmaceuticals Pvt. Ltd. 1. Manufacturing Process Of
Worsening of Cerebral Hyperemia by the Administration of Terlipressin in Acute Liver Failure with Severe Encephalopathy Followin
European Hyponatremia Guidelines
Auspar Attachment 2: Extract from the Clinical Evaluation Report For
Vasopressin and Its Analogues in Shock States: a Review Julien Demiselle1, Nicolas Fage1, Peter Radermacher2 and Pierre Asfar1*
Selepressin, a Novel Selective Vasopressin V1A
International Nonproprietary Names (Inn) for Biological and Biotechnological Substances
Vasopressin in Vasodilatory Shock
Continuous Terlipressin Versus Vasopressin Infusion in Septic Shock
An Inventory of Medicinal Products Causing Skin Rash: Clinical and Regulatory Lessons
HCC Surveillance
EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosisq
Management of Cirrhotic Ascites Under the Add-On Administration of Tolvaptan
Advances in Therapeutic Peptides Targeting G Protein-Coupled Receptors
Table S1: Clinical Trials of AVP Antagonists and Agonists
Management of Adult Patients with Ascites Due to Cirrhosis: Update 2012
EASL Clinical Practice Guidelines on the Management of Ascites, Spontaneous Bacterial Peritonitis, and Hepatorenal Syndrome in Cirrhosis
Argipressin (Vasopressin) 2021 Newborn Use Only
204485Orig1s000
A Guide Through Individual Monographs European Pharmacopoeia Training Session on Biologicals 4-5 February 2020 Olga Kolaj-Robin, Phd
Comparative Cardiac Effects of Terlipressin, Vasopressin, And
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Qualitative Detection of Desmopressin in Plasma by Liquid Chromatography
Australian Public Assessment Report for Terlipressin Acetate
AASLD Position Paper
AASLD Position Paper: the Management of Acute Liver Failure: Update 2011 William M
Restrictions in Use and Availability of Pharmaceuticals 2010 - 2018
Glypressin Solution for Injection GLYSOL006 04 April 2020 Page 1 of 6 NEW ZEALAND DATA SHEET
Study Protocol and Statistical Analysis Plan
Role of Vasopressin and Terlipressin in Refractory Shock Compared to Conventional Therapy in the Neonatal and Pediatric Populati
Summary of Product Characteristics